Gujarat Themis Biosyn Closes Trading Window from April 1st for Q4 FY26 Results
Gujarat Themis Biosyn Limited will close its trading window from April 1st, 2026. The window will reopen 48 hours after the declaration of audited financial results for the quarter ending March 31st, 2026.
This is a standard procedural announcement related to insider trading regulations and does not directly impact the company's financials or operations.
The announcement is a routine compliance update regarding the closure of the trading window and does not contain any material financial information or strategic developments.
Gujarat Themis Biosyn Limited has announced the closure of its trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's Code of Conduct.
The trading window will be closed effective from Wednesday, 1st April, 2026. It will be reopened 48 hours after the declaration of the audited financial results for the quarter ending 31st March, 2026, by the Board of Directors.
The company will intimate the date of the Board Meeting for considering these financial results in due course.
What to do with a filing like this
Themis Medicare Limited filed this with the NSE as a statutory disclosure, categorised under trading window disclosure. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Themis Medicare Limited. Read the original for the full detail.